Logo
A

ADARx Pharmaceuticals Inc.

67 employees

ADARx Pharmaceuticals, Inc., located in San Diego, is a clinical stage biotechnology company committed to turning cutting-edge science into life-saving therapeutics.  ADARx has developed proprietary RNA targeting platforms and oligonucleotide delivery technologies for inhibition, degradation, and editing disease-causing mRNA. ADARx has a growing pipeline of RNA targeting therapeutics for treating diseases across a range of therapeutic areas including genetic, cardiometabolic, complement-mediated diseases and central nervous system diseases.  We are well-financed by a syndicate of renowned VC firms. ADARx currently has multiple active programs in development. Our lead candidate is at the clinical stage.  Show more Show less

Investor insights

Funding rounds participated in

$200M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2019

Funding rounds raised

Total raised

$200M

from 3 investors over 1 rounds

A

ADARx Pharmaceuticals Inc. raised $200M on September 9, 2023

Investors: TCG Crossover, Bain Capital Life Sciences and + 14 Other investors

FAQ